Treatment failure. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Organisms12

Plasmodium falciparum Trypanosoma brucei gambiense Mycoplasma genitalium Neisseria gonorrhoeae HIV-1 Helicobacter pylori Methicillin-Resistant Staphylococcus aureus Salmonella paratyphi A Plasmodium vivax HIV Mycobacterium tuberculosis Staphylococcus aureus

Diseases52

Heart Failure Malaria, Falciparum Recurrence Kidney Failure, Chronic Failure to Thrive Liver Failure, Acute HIV Infections Liver Failure Gonorrhea Multiple Organ Failure Parasitemia Hodgkin Disease Acute Disease Disease Progression Cardiac Output, Low Pharyngeal Diseases Heart Failure, Systolic Acute Kidney Injury Staphylococcal Infections Chronic Disease Respiratory Insufficiency Neoplasm Recurrence, Local Prosthesis Failure Tuberculosis, Multidrug-Resistant Bacteremia Tuberculosis, Pulmonary Heart Failure, Diastolic Malaria, Vivax Community-Acquired Infections Helicobacter Infections Prosthesis-Related Infections Precursor Cell Lymphoblastic Leukemia-Lymphoma Pneumonia Renal Insufficiency Tuberculosis Scabies Otitis Media Trypanosomiasis, African Postoperative Complications Neoplasm Metastasis Breast Neoplasms Typhoid Fever Disease Models, Animal Sexually Transmitted Diseases, Bacterial Paratyphoid Fever Cardiomyopathy, Dilated Bacterial Infections Primary Ovarian Insufficiency Fever Leishmaniasis, Visceral Syphilis Soft Tissue Infections

Chemicals and Drugs92

Antimalarials Drug Combinations Sulfadoxine Pyrimethamine Anti-Bacterial Agents Chloroquine Artemisinins Amodiaquine Fluorenes Proguanil Atovaquone Dihydropteroate Synthase Cefixime Anti-HIV Agents Antiprotozoal Agents Antitubercular Agents Penicillin G Procaine Amoxicillin Metronidazole Melarsoprol Azithromycin Fluoxymesterone Ethanolamines Ceftriaxone Doxorubicin Anti-Infective Agents Tetrahydrofolate Dehydrogenase Vincristine Antimony Prednisone Mefloquine Vancomycin Anti-Retroviral Agents Cyclophosphamide Antineoplastic Agents Rifampin Sesquiterpenes Trimethoprim-Sulfamethoxazole Combination Vinblastine Antimony Sodium Gluconate Ethambutol Penicillins Clarithromycin Bleomycin Cytochromes b Mitolactol Etoposide Ciprofloxacin Protozoan Proteins Cisplatin DNA, Protozoan Isoniazid Naphthoquinones Ofloxacin Procarbazine Meglumine Pyrazinamide Niclosamide Biological Markers Reverse Transcriptase Inhibitors Bismuth Methotrexate HIV Protease Inhibitors Abortifacient Agents, Nonsteroidal Macrolides Quinolines Nevirapine Spectinomycin Daptomycin Triazines Dapsone Pyrimidines Prednisolone Quinine Trypanocidal Agents Fluorouracil Antifungal Agents Antiviral Agents Omeprazole Natriuretic Peptide, Brain HIV Protease Benzoxazines Anti-Infective Agents, Urinary Penicillin G Benzathine Megestrol Acetate Dacarbazine Piperazines Mitoxantrone Tamoxifen Cefazolin Triazoles Anti-Ulcer Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment59

Treatment Failure Treatment Outcome Drug Therapy, Combination Retrospective Studies Follow-Up Studies Prospective Studies Survival Analysis Prognosis Drug Administration Schedule Microbial Sensitivity Tests Parasitic Sensitivity Tests Antineoplastic Combined Chemotherapy Protocols Cohort Studies Survival Rate Disease-Free Survival Risk Factors Drug Monitoring Viral Load Combined Modality Therapy Kaplan-Meier Estimate Predictive Value of Tests Antiretroviral Therapy, Highly Active Salvage Therapy Double-Blind Method Equipment Failure CD4 Lymphocyte Count Severity of Illness Index Polymerase Chain Reaction Clinical Trials as Topic Administration, Oral Prosthesis Failure Remission Induction Retreatment Neoplasm Staging Randomized Controlled Trials as Topic Proportional Hazards Models Drug Substitution Multivariate Analysis Risk Assessment Infusions, Intravenous Directly Observed Therapy Reoperation Hospitalization Pilot Projects Stroke Volume Debridement Incidence Analysis of Variance Sensitivity and Specificity Disease Models, Animal Electrocoagulation Radiotherapy Dosage Logistic Models Patient Selection Bone Marrow Transplantation Prevalence Chi-Square Distribution Transplantation, Homologous Suburethral Slings

Psychiatry and Psychology2

Patient Compliance Medication Adherence

Phenomena and Processes21

Drug Resistance Time Factors Drug Resistance, Viral Drug Resistance, Bacterial Viral Load Genotype CD4 Lymphocyte Count Mutation Drug Resistance, Neoplasm Drug Resistance, Multiple Dose-Response Relationship, Drug Drug Resistance, Multiple, Bacterial Drug Resistance, Microbial Drug Resistance, Multiple, Viral Stroke Volume Cephalosporin Resistance Sensitivity and Specificity Hemodynamics Chi-Square Distribution Mutation, Missense Ventricular Function, Left

Information Science3

Survival Rate Incidence Prevalence

Named Groups2

Infant, Newborn Patient Dropouts

Health Care32

Treatment Failure Treatment Outcome Retrospective Studies Follow-Up Studies Prospective Studies Survival Analysis Cohort Studies Survival Rate Disease-Free Survival Risk Factors Kaplan-Meier Estimate Predictive Value of Tests Double-Blind Method Severity of Illness Index Patient Compliance Clinical Trials as Topic Randomized Controlled Trials as Topic Proportional Hazards Models Drug Substitution Multivariate Analysis Risk Assessment Hospitalization Pilot Projects Incidence Analysis of Variance Sensitivity and Specificity Medication Adherence Age Factors Logistic Models Patient Selection Prevalence Chi-Square Distribution

Geographicals16

Uganda Papua New Guinea Democratic Republic of the Congo Peru Cambodia India Kenya Thailand Angola Zambia Vietnam Indonesia Tanzania Malawi Mali Burkina Faso

Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Named Groups Health Care Geographicals

Treatment Failure Heart Failure Treatment Outcome Antimalarials Drug Combinations Sulfadoxine Pyrimethamine Drug Resistance Malaria, Falciparum Drug Therapy, Combination Retrospective Studies Anti-Bacterial Agents Chloroquine Recurrence Artemisinins Amodiaquine Follow-Up Studies Prospective Studies Fluorenes Proguanil Kidney Failure, Chronic Plasmodium falciparum Failure to Thrive Time Factors Atovaquone Dihydropteroate Synthase Survival Analysis Cefixime Drug Resistance, Viral Anti-HIV Agents Prognosis Liver Failure, Acute Drug Administration Schedule Antiprotozoal Agents HIV Infections Antitubercular Agents Microbial Sensitivity Tests Penicillin G Procaine Parasitic Sensitivity Tests Amoxicillin Antineoplastic Combined Chemotherapy Protocols Cohort Studies Metronidazole Survival Rate Disease-Free Survival Risk Factors Liver Failure Drug Resistance, Bacterial Gonorrhea Melarsoprol Drug Monitoring Azithromycin Fluoxymesterone Viral Load Combined Modality Therapy Ethanolamines Kaplan-Meier Estimate Multiple Organ Failure Parasitemia Predictive Value of Tests Antiretroviral Therapy, Highly Active Salvage Therapy Hodgkin Disease Uganda Trypanosoma brucei gambiense Genotype Ceftriaxone Doxorubicin Anti-Infective Agents Double-Blind Method Mycoplasma genitalium Tetrahydrofolate Dehydrogenase Acute Disease Vincristine Antimony Equipment Failure CD4 Lymphocyte Count Disease Progression Mutation Cardiac Output, Low Pharyngeal Diseases Prednisone Severity of Illness Index Neisseria gonorrhoeae Heart Failure, Systolic Acute Kidney Injury Staphylococcal Infections Patient Compliance Mefloquine Vancomycin HIV-1 Polymerase Chain Reaction Anti-Retroviral Agents Drug Resistance, Neoplasm Cyclophosphamide Antineoplastic Agents Chronic Disease Respiratory Insufficiency Rifampin Neoplasm Recurrence, Local

No FAQ available that match "treatment failure"